Chi L. Chiang
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma.
Journal: JCO precision oncology
Published: July 01, 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 15, 2026
In Reply to Cao and Wang.
Journal: International journal of radiation oncology, biology, physics
Published: February 16, 2026
Pre-existing CD95-based Temra immunity in patients with recurrent/metastatic nasopharyngeal carcinoma predicts response and hyperprogression to dual PD-L1 and TGFβ inhibition.
Journal: Clinical and translational medicine
Published: June 24, 2025
Compensatory Hypertrophy and Changes of Liver Function After Sequential Transarterial Chemoembolization, Stereotactic Body Radiation Therapy, and Immunotherapy (START-FIT) in Unresectable Hepatocellular Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: April 30, 2025
Survival impact of conversion therapy for Barcelona Clinic Liver Cancer (BCLC) stage B and C hepatocellular carcinoma-a propensity score matching analysis.
Journal: Hepatobiliary surgery and nutrition
Published: January 26, 2025
Efficacy of systemic therapy for advanced hepatocellular carcinoma based on etiology: A systematic review and network meta-analysis of randomized phase III trials.
Journal: Critical reviews in oncology/hematology
Published: January 01, 2025
Long-Term Outcome of Stereotactically Designed Hypofractionated Image Guided Radiation Therapy in Large, Unresectable Hepatocellular Carcinoma.
Journal: Practical radiation oncology
Published: October 16, 2024
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.
Journal: JAMA oncology
Published: October 10, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma.
Journal: JAMA oncology
Published: September 26, 2024
PD-L1 expression as a potential predictor of immune checkpoint inhibitor efficacy and survival in patients with recurrent or metastatic nasopharyngeal cancer: a systematic review and meta-analysis of prospective trials.
Journal: Frontiers in oncology
Published: February 15, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 15, 2023
Last Updated: 09/26/2026